Table 1: Baseline characteristics of participants who underwent SBS2 and standard EEG testing (n = 205).

From: Validation of a smartphone-based EEG among people with epilepsy: A prospective study

Age, median (interquartile range) years24 (18–32)
Female111 (54%)
Previously diagnosed with epilepsy188 (92%)
Most recent seizure
 Within past week57 (28%)
 Within past month61 (30%)
 Within past year27 (13%)
 More than one year ago60 (29%)
Seizure Characterization
 Loss of consciousness142 (69%)
 Staring spells34 (17%)
 Falling with stiffening and shaking115 (56%)
Current seizure treatment
 No AEDs19 (9%)
 Carbamazepine69 (34%)
 Lamotrigine8 (4%)
 Levetiracetam27 (13%)
 Phenobarbital42 (20%)
 Phenytoin77 (38%)
 Benzodiazepines17 (8%)
 Other AEDs3 (1%)
  1. SBS2: Smartphone Brain Scanner-2.
  2. EEG: Electroencephalogram.
  3. AEDs: Anti-epileptic drugs.
  4. Other AEDs included topiramate (2) and vigabatrin (1).